COVID-19 Updates
Conference Coverage
AI tool perfect in study of inflammatory diseases
A model that combines machine learning with clinical cues could help clinicians easily differentiate MIS-C from typhus, a new study found.
From the Journals
Long COVID and mental illness: New guidance
“Long COVID is real, and mental health conditions do not cause long COVID.”
From the Journals
Sensory comeback: New findings show the path to smell and taste recovery after COVID
“... There are still people suffering from it. ... It really has a significant psychological impact.”
From the Journals
A new long COVID explanation: Low serotonin levels?
The study found lower serotonin levels in long COVID patients, compared with patients who were diagnosed with acute COVID-19 but who fully...
Feature
Second infection hikes long COVID risk: Expert Q&A
There are people who think, “This is a nothing-burger anymore,” or “It’s not an issue anymore.” It’s still happening with the current variants.
From the Journals
Serious mental illness tied to 50% higher all-cause mortality risk after COVID
“From a public health perspective, our study has emphasized the need for early and timely preventative interventions (e.g. vaccination) for the...
From the Journals
Nirmatrelvir-ritonavir ineffective at reducing most post-COVID conditions
However, thromboembolic events were reduced.
News
mRNA vaccine cuts COVID-related Guillain-Barré risk
“While Guillain-Barré is extremely rare, people should be aware that having a COVID infection can increase their risk of developing the disorder,...
From the Journals
COVID coronary plaque infection confirms CV risk
The findings may not only explain the link between COVID and the increased risk of cardiovascular events but mark a starting point for new...
From the Journals
COVID, no matter the severity, linked with urologic effects in men
“Clinicians should be aware of the significantly higher incidence of [lower urinary tract infection] complications with COVID-19 in this patient...
From the Journals
Paxlovid tied to benefits in high-risk patients with COVID
No significant benefit was observed in patients who were not immunocompromised.